NO975862L - P-selektinligander og relaterte molekyler og fremgangsmåter - Google Patents

P-selektinligander og relaterte molekyler og fremgangsmåter

Info

Publication number
NO975862L
NO975862L NO975862A NO975862A NO975862L NO 975862 L NO975862 L NO 975862L NO 975862 A NO975862 A NO 975862A NO 975862 A NO975862 A NO 975862A NO 975862 L NO975862 L NO 975862L
Authority
NO
Norway
Prior art keywords
methods
ligands
determinant
selectin ligands
related molecules
Prior art date
Application number
NO975862A
Other languages
English (en)
Norwegian (no)
Other versions
NO975862D0 (no
Inventor
Brian Seed
Tara Pouyani
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of NO975862D0 publication Critical patent/NO975862D0/no
Publication of NO975862L publication Critical patent/NO975862L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4727—Mucins, e.g. human intestinal mucin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/473—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used alpha-Glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO975862A 1995-06-14 1997-12-12 P-selektinligander og relaterte molekyler og fremgangsmåter NO975862L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21395P 1995-06-14 1995-06-14
PCT/US1996/010043 WO1997000079A1 (fr) 1995-06-14 1996-06-11 Ligands de p-selectine et procedes et molecules associes___

Publications (2)

Publication Number Publication Date
NO975862D0 NO975862D0 (no) 1997-12-12
NO975862L true NO975862L (no) 1998-02-12

Family

ID=21690430

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975862A NO975862L (no) 1995-06-14 1997-12-12 P-selektinligander og relaterte molekyler og fremgangsmåter

Country Status (14)

Country Link
EP (1) EP0833650A4 (fr)
JP (1) JPH11508131A (fr)
KR (1) KR19990022954A (fr)
AR (1) AR003436A1 (fr)
AU (1) AU6272996A (fr)
BR (1) BR9608918A (fr)
CA (1) CA2224625A1 (fr)
CZ (1) CZ401497A3 (fr)
HU (1) HUP9901131A2 (fr)
IL (1) IL122590A0 (fr)
NO (1) NO975862L (fr)
TR (1) TR199701620T1 (fr)
WO (1) WO1997000079A1 (fr)
ZA (1) ZA965032B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2975599A (en) * 1998-02-27 1999-09-15 Genetics Institute Inc. P-selectin ligand protein including tetrameric fusion proteins
KR20030091953A (ko) * 2000-12-29 2003-12-03 사비언트 파마슈티컬즈 인코퍼레이티드 황산화된 부분을 함유하는 에피토프를 포함하는 분리된분자, 그러한 에피토프에 대한 항체, 및 그들의 용도
JP4599027B2 (ja) * 2002-10-30 2010-12-15 東洋水産株式会社 Ｌ−セレクチン結合阻害剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2183851T3 (es) * 1990-07-17 2003-04-01 Univ Oklahoma Ligando de gmp-140.
US5318890A (en) * 1991-05-06 1994-06-07 The Regents Of The University Of California Assays for inhibitors of leukocyte adhesion
CA2151142C (fr) * 1992-11-16 2001-10-02 Richard D. Cummings Ligand glycoproteique pour la p-selectine et ses modes d'utilisation
AU2361395A (en) * 1994-04-28 1995-11-29 Genetics Institute Inc. Novel P-selectin ligand protein

Also Published As

Publication number Publication date
CA2224625A1 (fr) 1997-01-03
ZA965032B (en) 1997-03-14
IL122590A0 (en) 1998-06-15
TR199701620T1 (xx) 1998-05-21
EP0833650A1 (fr) 1998-04-08
BR9608918A (pt) 1999-06-15
WO1997000079A1 (fr) 1997-01-03
NO975862D0 (no) 1997-12-12
JPH11508131A (ja) 1999-07-21
CZ401497A3 (cs) 1998-07-15
HUP9901131A2 (hu) 1999-07-28
AR003436A1 (es) 1998-08-05
EP0833650A4 (fr) 2005-01-19
AU6272996A (en) 1997-01-15
KR19990022954A (ko) 1999-03-25

Similar Documents

Publication Publication Date Title
Feinstein et al. Conformation of the free and antigen-bound IgM antibody molecules
Berndt et al. Purification and preliminary physicochemical characterization of human platelet membrane glycoprotein V.
Perutz Nature of haem–haem interaction
US5789376A (en) Transfusions with stabilized hemoglobin covalently bound to a nitroxide or polymers thereof
Marder et al. High Molecular Weight Derivatives of Human Fibrinogen Produced by Plasmin: III. THEIR NH2-TERMINAL AMINO ACIDS AND COMPARISON WITH THE “NH2-TERMINAL DISULFIDE KNOT
Kassis et al. Mechanism of action of cholera toxin on intact cells. Generation of A1 peptide and activation of adenylate cyclase.
NO20051950L (no) Konjugater av et polypeptid og en biokompatibel polymer
DE3853923D1 (de) Kationisierte antikörper für das austragen durch die blut-gehirn-schranke.
SE7407445L (fr)
AU7261994A (en) Hydrazino-type radionuclide chelators having an n3s configuration
WO1994029351A3 (fr) Anticorps
DK0413188T3 (da) Fremgangsmåde til fremstilling af umodificerede, intravenøst administrerbare IgM- og/eller IgA-holdige immunglobulinpræparater
DK644388D0 (da) Farmaceutiske praeparater indeholdende 3-hydroxy-smoeresyrederivater
DE59307354D1 (de) Bestimmung von peptidmotiven auf mhc-molekülen
NO176807C (no) Sammensmeltet gen som koder for et hybridprotein, samt fremgangsmåte for fremstilling av et hybridprotein som kodes av et sammensmeltet gen; vektor og sammensmeltet gen
Ronda et al. High-and low-affinity PEGylated hemoglobin-based oxygen carriers: Differential oxidative stress in a Guinea pig transfusion model
NO975862L (no) P-selektinligander og relaterte molekyler og fremgangsmåter
Elbaum et al. Surface activity of hemoglobin S and other human hemoglobin variants
EP0393895A3 (fr) Tamis moléculaires silicométallates et leur utilisation pour l'oxydation d'alcanes
DK369287A (da) Immunotoksiner og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende dem
Kayalar A model for proton translocation in biomembranes based on keto-enol shifts in hydrogen bonded peptide groups
MX9710114A (es) Ligandos de p-selectina y moleculas y metodos relacionados.
DK213589D0 (da) Antistoffer mod fibrin og immunogen til brug ved fremstilling deraf
MX9102087A (es) Complejos que contienen acidos s(+) fenilalcanos y acidos alfa-hidroxi alcanos.
Curtis et al. H‐2D antigens released by thymocytes and cell adhesion